Treatments for Hepatitis B reinfection following liver transplantation

FDA-approved drugs, patient assistance programs, and travel grants tracked on UniteRare for this condition.

ℹ
Treatment data is extracted from FDA drug labels, DailyMed, and openFDA through automated and AI-assisted pipelines that read both structured records and unstructured label text.
Report missing data

FDA-approved treatments (3)

Patient support programs (2)

Copay cards, manufacturer assistance, and foundation grants. Verification status shown on each card.

HepaGam B

Cangene Corporation

Unverified — confirm before calling
copay card
copay assistancePatient Assistance
Accepting applications

MAVYRET

AbbVie, Inc.

MAVYRET Patient Support (AbbVie Patient Assistance)

Link unavailable
Patient Assistance
Manufacturer Program
Accepting applications
1-800-222-6885Call for current details

More about Hepatitis B reinfection following liver transplantation